Keywords: گتییمر استات; adverse drug reaction; efficacy; glatiramer acetate; multiple sclerosis; safety; tolerability;
مقالات ISI گتییمر استات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گتییمر استات; Multiple sclerosis; Lymphocytes; Glatiramer acetate; Parameters; Treatment;
Keywords: گتییمر استات; Multiple sclerosis; Treatment; Interferon; Glatiramer acetate; Fumarates; Teriflunomide;
Keywords: گتییمر استات; MS; multiple sclerosis; MS-RR; relapsing-remitting multiple sclerosis; MS-SP; secondary progressive multiple sclerosis; MS-PP; primary progressive multiple sclerosis; IFN-Ã; interferon-beta; GA; glatiramer acetate; DMT; disease-modifying treatment; CIS;
Keywords: گتییمر استات; Copaxone; Glatiramer acetate; FOGA; Follow-on glatiramer acetate product; Non biological complex drug; NBCD; Substitutability;
Keywords: گتییمر استات; AHR; aryl hydrocarbon receptor; BBB; blood-brain barrier; CNS; central nervous system; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; EAE; experimental autoimmune encephalomyelitis; DC; dendritic cell; DMF; dimethyl fumarate; D
Keywords: گتییمر استات; CHI3L1; chitinase 3-like 1; MS; multiple sclerosis; RRMS; relapsing-remitting multiple sclerosis; CIS; clinically isolated syndrome; DMT; disease modifying therapies; IFNβ; interferon-beta; GA; glatiramer acetate; Chitinase 3-like 1; Interferon-beta; Gla
Keywords: گتییمر استات; MS; Multiple Sclerosis; PRIMS; Pregnancy In Multiple Sclerosis; EDSS; Expanded Disability Status Scale; DMT; disease modifying therapy; IVIg; intravenous immunoglobulin; GA; glatiramer acetate; INF; interferon; IM; intramuscular; EA; epidural analgesia; C
Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetate
Keywords: گتییمر استات; % RTR; Retention Time Ratio Percent; ATP; Analytical Target Profile; CQA; Critical Quality Attribute; CV; Coefficient of Variation; GA; Glatiramer Acetate; ICH; The International Conference on Harmonisation of Technical Requirements for Registration of Ph
Keywords: گتییمر استات; RRMS; Disease activity free status; Clinical trial; Interferon beta-1a; Glatiramer acetate;
Keywords: گتییمر استات; AHSCT; autologous hematopoietic stem cell transplant; ARR; annualized relapse rate; BVL; brain volume loss; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; GA; glatiramer acetate; HRQoL; health-related quality of life; IFN; interfe
Keywords: گتییمر استات; Disease-modifying treatments; Generic drugs; Glatiramer acetate; Multiple sclerosis; Copaxone; Glatopa;
Keywords: گتییمر استات; MS; multiple sclerosis; DMT; disease modifying therapy; RRMS; relapsing-remitting MS; NEDA; no evidence of disease activity; N/E; new or enlarging; GdE; gadolinium enhancing; KP; knowledge program; EQ-5D; European Quality of Life 5-Dimensions; PS; Perform
Keywords: گتییمر استات; Multiple sclerosis; Interferon beta; Glatiramer acetate; Suboptimal response; Disability; Prediction;
Keywords: گتییمر استات; Multiple sclerosis; Gene expression; Glatiramer acetate; Microarray; Therapeutic equivalence;
Keywords: گتییمر استات; AAV; adeno-associated virus; BDNF; brain-derived neurotrophic factor; CNP; 2â²,3â²-cyclic nucleotide 3â²-phosphodiesterase; CNS; central nervous system; CNTF; ciliary neurotrophic factor; CNTFRα; ciliary neurotrophic factor receptor alpha; Cop-1; copa
Keywords: گتییمر استات; Multiple sclerosis; Interferon beta; Glatiramer acetate; Compliance; Satisfaction; Quality of lifeEsclerosis múltiple; Interferón beta; Acetato de glatirámero; Cumplimiento; Satisfacción; Calidad de vida
Keywords: گتییمر استات; GA; glatiramer acetate; RRMS; relapsing-remitting multiple sclerosis; sLep-R; soluble leptin-receptor; MPO; myeloperoxidase; sCD40-L; soluble CD40 ligand; sTNF-R; soluble tumor necrosis factor-receptor; MCP-1; monocyte chemoattractant protein 1; sICAM-1
Keywords: گتییمر استات; 4HNE; 4-hydroxy-2-nonena 1; AA-NAT; arylalkylamine N-acetylatransferase; AFMK; N1-acetyl-N2-formyl-5-methoxykynuramine; AHr; aryl hydrocarbon receptor; AMK; N1-acetyl-5-methoxykynuramine; Apo; apolipoprotein; cAMP; cyclic adenosine monophosphate; B2-adr;
Keywords: گتییمر استات; Fingolimod; Glatiramer acetate; Interferon; Multiple sclerosis; Natalizumab; Prescribing; Utilisation
Keywords: گتییمر استات; Clinical practice; Disability; Long-term effectiveness; Glatiramer acetate; Multiple sclerosis; Relapse
Keywords: گتییمر استات; BBB; blood-brain barrier; CNS; central nervous system; DMF; dimethyl fumarate; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; FDA; Food and Drug Administration; GA; glatiramer acetate; JCV; John Cunningham virus; MRI; magnetic res
Keywords: گتییمر استات; Stress; Copaxone; Copolymer-1; Glatiramer acetate; Neuroprotection; Neuronal survival; CNS injury; Fluoxetine (Prozac);
Keywords: گتییمر استات; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Nasal drug administration; Glatiramer acetate; Cannabidiol; Neurogenesis;
Keywords: گتییمر استات; MS; Multiple sclerosis; EAE; Experimental autoimmune encephalomyelitis; GA; Glatiramer acetate; MOG; Oligodendrocyte glycoprotein; PLP; Proteolipid protein; CNS; Central nervous system; MTR; Magnetization transfer ratio; DTI; Diffusion tensor imaging; VBA
Effect of switching from glatiramer acetate 20â¯mg/daily to glatiramer acetate 40â¯mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study
Keywords: گتییمر استات; Multiple sclerosis; MRI; DTI; GM; WM; Tract based spatial statistics; Glatiramer acetate;
Decreased serum levels of sCD40L and IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis
Keywords: گتییمر استات; Multiple sclerosis; sCD40L; IL-31; Glatiramer acetate; IFN-β;
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Keywords: گتییمر استات; SIRT1; PBMCs; Multiple sclerosis; Histone trimethylation; Glatiramer acetate; Biomarker; AUC; area under the curve; CNS; central nervous system; CPT; cell preparation tubes; EAE; experimental autoimmune encephalomyelitis; EDSS; expanded disability status
Eficacia del tratamiento inmunomodulador con interferón-β o acetato de glatirámero en las uveÃtis asociadas a esclerosis múltiple
Keywords: گتییمر استات; Interferón-β; Acetato de glatirámero; UveÃtis asociada a esclerosis múltiple; Esclerosis múltiple; UveÃtis; Interferon-β; Glatiramer acetate; Multiple sclerosis-associated uveitis; Multiple sclerosis; Uveitis;
IL-27: a potential biomarker for responders to glatiramer acetate therapy
Keywords: گتییمر استات; Multiple sclerosis; Glatiramer acetate; IL-27; IL-10;
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10Â years in responder multiple sclerosis patients
Keywords: گتییمر استات; MS; multiple sclerosis; CNS; central nervous system; Treg; regulatory T cells; RR; relapsing remitting; NK; natural killer; GA; glatiramer acetate; IL; interleukin; TGF; transforming grow factor; TNF; tumor necrosis factor; DC; Dendritic cells; CReSM; Cen
Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosisâ
Keywords: گتییمر استات; cost-effectiveness; dimethyl fumarate; economic evaluation; glatiramer acetate; interferon-β; teriflunomide;
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis
Keywords: گتییمر استات; SIRT1; Multiple sclerosis; Glatiramer acetate; Biomarker; Histone H3; Methylation;
Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis
Keywords: گتییمر استات; MS; multiple sclerosis; EAE; experimental autoimmune encephalomyelitis; P-Cho; propargylcholine; GA; glatiramer acetate; PLP; proteolipid protein; CNS; central nervous system; Multiple sclerosis (MS); Experimental autoimmune encephalomyelitis (EAE); Remye
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
Keywords: گتییمر استات; Multiple sclerosis; Glatiramer acetate; Cytokines; Biomarkers;
Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate
Keywords: گتییمر استات; Rett syndrome; glatiramer acetate; gait; clinical trial;
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
Keywords: گتییمر استات; Huntington's disease; Glatiramer acetate; BDNF; Astrocytes; Neuroprotection
MicroRNAs associated with the pathogenesis of multiple sclerosis
Keywords: گتییمر استات; BBB; blood-brain barrier; BMI1; B lymphoma Mo-MLV insertion region 1 homolog; CAPS-3; caspase-3; CEBPB; CCAAT/enhancer-binding protein beta; CNS; central nervous system; EAE; experimental autoimmune encephalomyelitis; GA; Glatiramer acetate; HIF-1; hypo
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway
Keywords: گتییمر استات; Glatiramer acetate; Tumor necrosis factor-alpha (TNF-α); Endothelial dysfunction; Monocytes adhesion; NF-κB
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40Â mg three-times weekly versus 20Â mg daily in patients with relapsing-remitting multiple sclerosis
Keywords: گتییمر استات; Glatiramer acetate; Relapsing-remitting multiple sclerosis; Dose regimen; Safety; Convenience; Patient adherence;
Cumplimiento terapéutico con terapias modificadoras de la enfermedad de primera lÃnea en pacientes con esclerosis múltiple. Estudio COMPLIANCE
Keywords: گتییمر استات; Esclerosis múltiple; Interferón beta; Acetato de glatirámero; Cumplimiento; Satisfacción; Calidad de vida; Multiple sclerosis; Interferon beta; Glatiramer acetate; Compliance; Satisfaction; Quality of life;
Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10
Keywords: گتییمر استات; Multiple sclerosis; Interleukin-6; Interleukin-10; Glatiramer acetate; B lymphocytes;
Demonstration of equivalence of a generic glatiramer acetate (Glatopaâ¢)
Keywords: گتییمر استات; ANDA; Abbreviated New Drug Application; APC; antigen-presenting cell; CNS; central nervous system; DEA; diethylamine; EAE; experimental autoimmune encephalomyelitis; ELISA; enzyme-linked immunosorbent assay; FDA; Food and Drug Administration; GA; glatiram
Acetato de glatirámero: reacciones adversas no comunes
Keywords: گتییمر استات; Esclerosis múltiple; Adherencia; Enfermera; Acetato de glatirámeroMultiple sclerosis; Adherence; Nursing; Glatiramer acetate
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath
Keywords: گتییمر استات; Epilepsy; Demyelination; Glatiramer acetate; Pentylenetetrazol;
Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis
Keywords: گتییمر استات; EAE; experimental allergic encephalomyelitis; GA; glatiramer acetate; DC; dendritic cells; OPN; osteopontin; TLR; toll related receptor; MyD88; myeloid differentiation primary response gene 88; IL; interleukin; Th; T helper; LN; lymph node; Dendritic cell
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors
Keywords: گتییمر استات; Experimental autoimmune encephalomyelitis; Multiple sclerosis; BDNF and TrkB tyrosine kinase receptor; Neuregulin1; Glatiramer acetate;
The mechanism of action of glatiramer acetate in multiple sclerosis and beyond
Keywords: گتییمر استات; MS; Multiple sclerosis; EAE; Experimental autoimmune encephalomyelitis; CNS; Central nervous system; BBB; Blood brain barrier; MBP; Myelin basic protein; MOG; Myelin oligodendrocyte glycoprotein; PLP; Myelin proteolipid protein; GA; Glatiramer acetate; AP
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis
Keywords: گتییمر استات; Multiple sclerosis; Pregnancy; Interferon beta; Glatiramer acetate
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model
Keywords: گتییمر استات; Myelin repair; Glatiramer acetate; Microglial cells; Oligodendrocytes